Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?

TheMotleyFool

0 0

Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?

We now have a pretty good idea how much COVID-19 vaccines will cost Uncle Sam. Last week, The U.S. government announced a deal with Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) to buy 100 million doses of the two partners' lead coronavirus vaccine candidate for $1.95 billion. That translates to a price tag of $19.50 per dose.

But Moderna (NASDAQ: MRNA) is considering pricing its COVID-19 vaccine at more than 50% higher than Pfizer's price tag for its vaccine, according to a report in the Financial Times. Will Moderna be able to get away with such a higher price?

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share